CD274 and digestive system neoplasm: However, PD-(L)1 inhibitors were associated with a higher frequency of any grade and high-grade immune-related AEs.<h4>Conclusions</h4>PD-(L)1 inhibitors appeared to be effective and safe for cancer treatment, except for gastrointestinal tumors; however, the quality of the evidence is not convincing.